Search Results - "Giordano, Philip"

Refine Results
  1. 1

    Analysis of Pooled Phase III Efficacy Data for Delafloxacin in Acute Bacterial Skin and Skin Structure Infections by Giordano, Philip A, Pogue, Jason M, Cammarata, Sue

    Published in Clinical infectious diseases (08-04-2019)
    “…Abstract Background Delafloxacin is an oral or intravenous (IV) antibiotic indicated for the treatment of acute bacterial skin and skin structure infections…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Sex differences in time course and diagnostic accuracy of GFAP and UCH-L1 in trauma patients with mild traumatic brain injury by Papa, Linda, Brophy, Gretchen M., Alvarez, Wilmer, Hirschl, Robert, Cress, Marshall, Weber, Kurt, Giordano, Philip

    Published in Scientific reports (22-07-2023)
    “…Glial Fibrillary Acidic Protein (GFAP) and Ubiquitin C-terminal hydrolase (UCH-L1) have been FDA-approved for clinical use in mild and moderate traumatic brain…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    A Case of Brown Widow Envenomation in Central Florida by Earwood, Ryan C, Ladde, Jay, Giordano, Philip A

    Published in Curēus (Palo Alto, CA) (13-07-2020)
    “…Latrodectus geometricus, also known as the brown widow or brown button spider, is an unrenowned relative of the American black widow. While brown widow…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Oral β-lactams applied to uncomplicated infections of skin and skin structures by Jacobs, Michael R, Jones, Ronald N, Giordano, Philip A

    “…Abstract Uncomplicated skin and skin structure infections (uSSSIs) include impetigo, erysipelas, folliculitis, simple abscesses, and cellulitis. Their common…”
    Get full text
    Journal Article
  15. 15

    Cefdinir vs. cephalexin for mild to moderate uncomplicated skin and skin structure infections in adolescents and adults by Giordano, Philip A., Elston, Dirk, Akinlade, Bolanle K., Weber, Kurt, Notario, Gerard F., Busman, Todd A., Cifaldi, Mary, Nilius, Angela M.

    Published in Current medical research and opinion (01-12-2006)
    “…ABSTRACT Objectives: To compare the efficacy and safety of cefdinir to that of cephalexin in adolescents and adults with mild to moderate uncomplicated skin…”
    Get full text
    Journal Article
  16. 16

    Protein C as an early biomarker to distinguish pneumonia from sepsis by Gutovitz, Scott, MD, Papa, Linda, MD, Jimenez, Edgar, MD, Falk, Jay, MD, Wieman, Leighann, MD, Sawyer, Sandra, BA, Giordano, Philip, MD

    Published in Journal of critical care (01-06-2011)
    “…Abstract Purpose Patients with pneumonia often are unrecognized as also having sepsis. We evaluated protein C, as a potential biomarker, to differentiate…”
    Get full text
    Journal Article
  17. 17

    A Randomized Clinical Trial of Single-Dose Versus Weekly Dalbavancin for Treatment of Acute Bacterial Skin and Skin Structure Infection by Dunne, Michael W., Puttagunta, Sailaja, Giordano, Philip, Krievins, Dainis, Zelasky, Michael, Baldassarre, James

    Published in Clinical infectious diseases (01-03-2016)
    “…Background. Acute bacterial skin and skin structure infections (ABSSSIs) are a cause of significant morbidity and therapy can be a burden to the healthcare…”
    Get full text
    Journal Article
  18. 18

    A Liquid Adhesive Bandage for the Treatment of Minor Cuts and Abrasions by Eaglstein, William H., Sullivan, Tory P., Giordano, Philip A., Miskin, Barry M.

    Published in Dermatologic surgery (01-03-2002)
    “…Background. Octyl‐2‐cyanoacrylate is U.S. Food and Drug Administration (FDA) approved for the closure of incisions and lacerations. In animal studies, a more…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Single-Dose Oritavancin in the Treatment of Acute Bacterial Skin Infections by Corey, G. Ralph, Kabler, Heidi, Mehra, Purvi, Gupta, Sandeep, Overcash, J. Scott, Porwal, Ashwin, Giordano, Philip, Lucasti, Christopher, Perez, Antonio, Good, Samantha, Jiang, Hai, Moeck, Greg, O'Riordan, William

    Published in The New England journal of medicine (05-06-2014)
    “…In this trial, a new lipoglycopeptide antibiotic with a prolonged half-life, oritavancin, was compared with vancomycin in the treatment of skin and soft-tissue…”
    Get full text
    Journal Article